{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:42:06Z","timestamp":1770496926926,"version":"3.49.0"},"reference-count":26,"publisher":"Cambridge University Press (CUP)","issue":"5","license":[{"start":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T00:00:00Z","timestamp":1183420800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We examined the prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and past and subsequent incidence of disease. The levels of specific IgG antibodies against mumps were tested in 3330 residual sera collected during 1997\u20131998 from an age-stratified population sample. Against the background of a consistent MMR vaccination coverage of &gt;90%, the age- and sex-adjusted seropositivity to mumps was 77\u00b70%. No significant differences between genders were found. Seropositivity in the 10\u201313 years age group, born just before the introduction of the MMR vaccine, was the lowest (59%). These birth cohorts were the target of an outbreak of mumps in 2005 that occurred among high-school students and military recruits. A trend of waning immunity was observed between the first and second vaccine doses. The seroepidemiological data demonstrate that immunity levels below the herd immunity threshold, along with social mixing and crowded conditions facilitated the occurrence of mumps outbreaks. Periodical serosurveys are an essential component in the evaluation of the vaccination policy against mumps.<\/jats:p>","DOI":"10.1017\/s0950268807008989","type":"journal-article","created":{"date-parts":[[2007,7,3]],"date-time":"2007-07-03T12:04:34Z","timestamp":1183464274000},"page":"688-693","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease"],"prefix":"10.1017","volume":"136","author":[{"given":"Kh.","family":"MUHSEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"ABOUDY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"MENDELSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u00a0S.","family":"GREEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"COHEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2007,7,3]]},"reference":[{"key":"S0950268807008989_ref002","first-page":"173","article-title":"Mumps epidemic\u00a0\u2013\u00a0United kingdom, 2004\u20132005","volume":"55","year":"2006","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268807008989_ref014","first-page":"50","volume-title":"Israel Center for Disease Control","year":"2004"},{"key":"S0950268807008989_ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.072"},{"key":"S0950268807008989_ref013","first-page":"88","article-title":"Mumps incidence in Israel\u00a0\u2013\u00a0impact of MMR vaccine","volume":"18","author":"Slater","year":"1990","journal-title":"Public Health Reviews"},{"key":"S0950268807008989_ref008","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.20.2643"},{"key":"S0950268807008989_ref007","first-page":"R21","article-title":"Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule","volume":"7","author":"Gay","year":"1997","journal-title":"Communicable Disease Report. CDR Review"},{"key":"S0950268807008989_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90420-A"},{"key":"S0950268807008989_ref016","first-page":"1","article-title":"Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia","author":"Tischer","year":"2007","journal-title":"Epidemiology and Infection"},{"key":"S0950268807008989_ref009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312101"},{"key":"S0950268807008989_ref019","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007326621525"},{"key":"S0950268807008989_ref025","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00064-8"},{"key":"S0950268807008989_ref005","first-page":"1","article-title":"Mumps surveillance\u00a0\u2013\u00a0United States, 1988\u20131993. Morbidity and Mortality Weekly Report","volume":"44","author":"van Loon","year":"1995","journal-title":"CDC Surveillance Summaries"},{"key":"S0950268807008989_ref026","doi-asserted-by":"publisher","DOI":"10.1086\/314957"},{"key":"S0950268807008989_ref023","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00199-05"},{"key":"S0950268807008989_ref001","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7500.1132"},{"key":"S0950268807008989_ref004","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"key":"S0950268807008989_ref021","first-page":"1443","volume-title":"Vaccines","author":"Fine","year":"2004"},{"key":"S0950268807008989_ref003","doi-asserted-by":"publisher","DOI":"10.1007\/BF02276717"},{"key":"S0950268807008989_ref024","first-page":"559","article-title":"Update: multistate outbreak of mumps\u00a0\u2013\u00a0United States, January 1\u2013May 2, 2006","volume":"55","year":"2006","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268807008989_ref015","doi-asserted-by":"publisher","DOI":"10.2807\/esm.02.04.00167-en"},{"key":"S0950268807008989_ref017","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022567811765"},{"key":"S0950268807008989_ref006","first-page":"1","article-title":"Measles, mumps, and rubella\u00a0\u2013\u00a0vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"Morbidity and Mortality Weekly Report. Recommendations and Reports"},{"key":"S0950268807008989_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2005.09.009"},{"key":"S0950268807008989_ref012","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007663429371"},{"key":"S0950268807008989_ref018","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803001584"},{"key":"S0950268807008989_ref011","first-page":"25","volume-title":"The Israel Center for Disease Control","year":"2003"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268807008989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T23:50:45Z","timestamp":1556668245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268807008989\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,3]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0950268807008989"],"URL":"https:\/\/doi.org\/10.1017\/s0950268807008989","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,3]]}}}